ArticleMethodsX2025
A method for siRNA-mediated knockdown of target genes in RA-induced neurogenesis using P19 cells.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a comprehensive protocol for siRNA-mediated knockdown in the differentiation of P19 cells into neuronal-like cells. Utilizing a retinoic acid (RA)-induced neurogenesis model, P19 cells were cultured under specific conditions that facilitated the formation of embryoid bodies (EBs), which were subsequently differentiated into neuronal-like cells. In this investigation, we specifically targeted the Nfe2l1 gene using siRNA transfection to assess the efficiency and effectiveness of our protocol throughout the neuronal differentiation process. Validation of the differentiation was performed through quantitative reverse transcription PCR (RT-qPCR) analysis, measuring the expression levels of key neuronal markers, including Map2 and Pax6 along with the pluripotency marker Oct4. Additionally, the efficiency of the siRNA-mediated knockdown was confirmed by western blot analysis, which demonstrated significant gene silencing at protein levels. These findings underscore the potential of siRNA technology in elucidating gene function during neuronal differentiation and highlight the critical role of targeted gene silencing in advancing neurogenesis research. Furthermore, this study provides a robust and reliable protocol for gene knockdown in neuronal-like cells derived from P19 cells, thereby facilitating further investigations into the intricate molecular mechanisms that govern neurogenesis, neuronal maturation, and overall brain development.•Developed a novel protocol for targeted gene knockdown in P19 cells during neuronal differentiation.•Successful silencing of the Nfe2l1 gene during neuronal differentiation, validated by western blot.•This study provides a reliable protocol for gene knockdown in neuronal differentiation, aiding functional studies of genes in neurogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.